Adaptimmune Therapeutics
ADAP
#9421
Rank
ยฃ45.09 M
Marketcap
ยฃ0.18
Share price
-12.60%
Change (1 day)
-83.73%
Change (1 year)

Adaptimmune Therapeutics (ADAP) - Cash on Hand

Cash on Hand as of December 2024 : ยฃ0.11 Billion

According to Adaptimmune Therapeutics's latest financial reports the company has ยฃ0.11 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Adaptimmune Therapeutics - Cash on Hand chart (from 2014 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31ยฃ0.11 B-31.8%
2022-12-31ยฃ0.16 B-38.23%
2021-12-31ยฃ0.27 B1.35%
2020-12-31ยฃ0.27 B295.61%
2019-12-31ยฃ68.28 M-57.75%
2018-12-31ยฃ0.16 B4.87%
2017-12-31ยฃ0.15 B4.78%
2016-12-31ยฃ0.14 B
2015-06-30ยฃ0.18 B500.45%
2014-06-30ยฃ30.1 M18379.59%
2013-06-30ยฃ0.16 M-91.55%
2012-06-30ยฃ1.92 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
ยฃ0.72 B 508.90%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ31.52 M-73.42%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.28 B 142.42%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
ยฃ0.86 B 633.01%๐Ÿ‡บ๐Ÿ‡ธ USA